drugset / Trial / NCT00127192
A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2005-07
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 25 mg | Oral |
| Subject | Sitagliptin | Small molecule | 50 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |
| Subject | Sitagliptin | Small molecule | 200 mg | Oral |